Refusing to slow down since the start of the new year, shares of Tempus AI (NASDAQ: TEM) have skyrocketed nearly 99% since ...

Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) have received an average rating of “Moderate Buy” from the twelve ...

TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...

Tempus AI, Inc. (NASDAQ:TEM) grew its share prices by 29.7 percent week-on-week to end Friday’s trading at $89.44 apiece ...

Insiders sold more Tempus AI (TEM) stock last week as shares of the medical technology firm continue to notch a series of fresh all-time highs.

William Blair cut shares of Tempus AI (NASDAQ:TEM – Free Report) from an outperform rating to a market perform rating in a ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will present at the TD Cowen 45th Annual Health Care Conference on March ...

Looking at options history for Tempus AI (NASDAQ:TEM) we detected 21 trades. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with ...

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...

Tempus Ai (NASDAQ: TEM) stock is seeing an explosive valuation surge in Tuesday's trading thanks to a pair of catalysts. The healthcare software company's share price was up 35.8% as of 3:15 p.m ...

Looking at options history for Tempus AI (NASDAQ:TEM) we detected 24 trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with ...

Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) in ...